RS
IBIO icon

R Squared’s iBio IBIO Stock Holding History

R Squared’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$28.5K Buy
+24,153
New +$33.3K 0.02% 478

Other funds holding IBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Noesis Capital Mangement
Noesis Capital Mangement Boca Raton, Florida $843M AUM 33.46% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

R Squared's IBIO Position: Q3 2026 in Review

R Squared opened a new position in iBio (IBIO) in Q3 2026: 24,153 shares worth $28.5K. The stake represents 0.02% of the portfolio and ranks #478 among its holdings.

13 funds tracked by Wall St. Rank hold IBIO as of Q3 2026.

  • R Squared held 24,153 shares of iBio worth $28.5K as of Q3 2026.
  • iBio was a new R Squared position in Q3 2026.
  • iBio made up 0.02% of R Squared's portfolio in Q3 2026, its #478 holding.
  • 13 funds tracked by Wall St. Rank held iBio as of Q3 2026.

Based on R Squared's 13F filing for Q3 2026, filed 6 Nov 2026.